Governance
Medical and Pharmacy Reviewer Directory
Released: · Last reviewed:
Reviewers on this site are named, and their National Provider Identifiers are verified against the public CMS NPPES registry. Every page is medically reviewed by both: Dr. Jonathan Snipes, MD, who leads on medical, dosing, safety and research content, and Kim Callender, NP (FNP-BC), who leads on provider, cost and pharmacy content. Pages are researched and drafted by Dr. Parmis, Medical Researcher — a separate role for which no clinical-review authority is asserted.
Key takeaways
- Two medical reviewers hold verified NPI records checked against the CMS NPPES registry.
- Both reviewers review every page; each has a published area of emphasis.
- Research and drafting is a distinct role, held by Dr. Parmis, for which no clinical-review authority is asserted.
- Clinical review confirms language accuracy and creates no clinician-patient relationship.
- Every reviewed page displays a separate medically reviewed date.
| Clinical reviewers | 2, both with NPI verified in CMS NPPES |
|---|---|
| Research role | 1 — Dr. Parmis, Medical Researcher (no clinical-review authority asserted) |
| Verification method | NPI checked against the public CMS NPPES registry |
| Review coverage | Both reviewers review every page; emphasis: medical/dosing/safety/research (Dr. Snipes) and provider/cost/pharmacy (Kim Callender) |
| Displayed | Researcher, both reviewers and the review date on every page |
Who reviews clinical content?
Who researches and drafts pages?
Pages are researched and drafted by Dr. Parmis Mojarab, credited in bylines as “Dr. Parmis”, Medical Researcher, Western University of Health Sciences. The role is distinct from medical review: no clinical-review authority is asserted for it, and every page she researches is medically reviewed by both reviewers above.
What does NPI verification actually prove?
That the individual holds a National Provider Identifier registered in the public CMS database with the stated name and credential. It confirms the person is a real, identifiable clinician rather than an invented byline. It does not by itself confirm specialty board certification or licensure status in a given state, which are separate records.
How much of this site's data is actually verified?
| Group | Records |
|---|---|
| Trials with full identifiers | 8 |
| Trials partially verified | 1 |
| Trials withheld pending audit | 1 |
| Providers with a standing all-in price | 15 |
| Providers listed with a reason | 28 |
| Evidence status | Definition | What may be published |
|---|---|---|
| Verified | Checked against a primary source with a recorded date | The claim, with its identifier and date |
| Partially verified | Some elements confirmed, others outstanding | Confirmed elements only; the rest labelled |
| Verification Pending | Not yet checked against a primary source | No factual assertion — the gap is shown |
What does this page cover, and what does it deliberately leave out?
This page addresses Credentials, licenses, specialties and review scopes and conflicts, organised around the primary question of tirzepatide medical reviewers. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.
| Element | Treatment here | Evidence basis |
|---|---|---|
| Credentials | Covered on this page | Regulatory or policy source |
| Licenses | Covered on this page | Regulatory or policy source |
| Specialties | Covered on this page | Regulatory or policy source |
| Review scopes and conflicts | Covered on this page | Regulatory or policy source |
| Individualized clinical instruction | Deliberately not covered | Belongs with the corrections process |
What are the limits of what this page can tell you?
Every page on this site rests on a specific published policy, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for the corrections process.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
Any of the following would change what this page concludes:
- New primary evidence bearing directly on tirzepatide medical reviewers.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
Frequently asked questions
Who reviews content on this site?
Both named medical reviewers — Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC) — review every page; their NPI records are verified in the CMS NPPES registry.
What does NPI verification confirm?
That the reviewer is a real, identifiable clinician registered in the public CMS database. It does not by itself confirm board certification or state licensure.
Is the medical researcher a medical reviewer?
No. Dr. Parmis researches and drafts pages; no clinical-review authority is asserted for that role, and medical review is done by the two reviewers.
Does review make this medical advice?
No. Review checks published language and creates no clinician-patient relationship.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
| 2026-09-04 | Shared cost components and disclosures rebuilt from the 2026-09-04 dataset (NexLife September 2026 card re-read live; Yucca Health and a program since removed from this site added; NexLife disclosed as a commercial partner, labelled where it appears). |
| 2026-11-08 | Directory updated: both reviewers review every page (areas of emphasis kept); the editorial-governance role (Editorial Auditor) replaced by Dr. Parmis's role as Medical Researcher, Western University of Health Sciences, who researches and drafts pages. Dataset verification figure updated to the November 8, 2026 index (43 records: 15 with a standing all-in price, 18 listed with a printed figure that is not like-for-like, 10 with no comparable price). |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.